0.9680
-0.0210
(-2.12%)
At close: April 17 at 4:00:01 PM EDT
0.9680
0.00
(0.00%)
After hours: April 17 at 4:05:06 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | 0.11 | -0.64 | -1.35 | 2.26 |
Low Estimate | -1.08 | -0.76 | -4.04 | -0.2 |
High Estimate | 1.3 | -0.52 | 1.35 | 4.72 |
Year Ago EPS | -1.25 | -1.5 | -5.97 | -1.35 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 3 |
Avg. Estimate | -- | 2.88M | 10.45M | 61.36M |
Low Estimate | -- | -- | -- | 38M |
High Estimate | -- | 4.8M | 16M | 78.29M |
Year Ago Sales | -- | -- | -- | 10.45M |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 487.10% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | -1.5 | -1.12 | -1.5 | -1.25 |
EPS Actual | -1.25 | -1.5 | -5.8 | -1.3 |
Difference | 0.25 | -0.38 | -4.3 | -0.05 |
Surprise % | 16.67% | -33.33% | -286.67% | -4.00% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0.11 | -0.64 | -1.35 | 2.26 |
7 Days Ago | 1.3 | -0.52 | 1.35 | 2.98 |
30 Days Ago | 1.3 | -0.52 | 1.35 | 2.98 |
60 Days Ago | -1.25 | -1 | 1.29 | 2.5 |
90 Days Ago | -1.25 | -1 | 1.29 | 2.5 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | 1 |
Up Last 30 Days | -- | -- | 1 | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
CTXR | 108.80% | 57.33% | 77.47% | 268.03% |
S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Upgrades & Downgrades
Maintains | D. Boral Capital: Buy to Buy | 2/18/2025 |
Maintains | D. Boral Capital: Buy to Buy | 1/7/2025 |
Upgrade | D. Boral Capital: Hold to Buy | 12/30/2024 |
Downgrade | D. Boral Capital: Buy to Hold | 11/22/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 11/12/2024 |
Maintains | D. Boral Capital: Buy to Buy | 11/11/2024 |
Related Tickers
ATNM Actinium Pharmaceuticals, Inc.
1.2100
-3.20%
CVM CEL-SCI Corporation
0.2548
-1.05%
SXTP 60 Degrees Pharmaceuticals, Inc.
3.1600
-0.32%
RGLS Regulus Therapeutics Inc.
2.0600
+6.19%
HEPA Hepion Pharmaceuticals, Inc.
0.3221
-6.09%
MAIA MAIA Biotechnology, Inc.
1.5500
+0.65%
SGMT Sagimet Biosciences Inc.
2.2100
+9.41%
ENSC Ensysce Biosciences, Inc.
1.7600
-6.38%
CLSD Clearside Biomedical, Inc.
0.8600
-1.13%
BDRX Biodexa Pharmaceuticals Plc
1.4300
-0.69%